Resnik D
Account Res. 2020; 28(7):428-455.
PMID: 33231115
PMC: 8184880.
DOI: 10.1080/08989621.2020.1855149.
Rooney L, Covington L, Dedier A, Samuel B
J Empir Res Hum Res Ethics. 2019; 14(2):95-106.
PMID: 30866722
PMC: 6448580.
DOI: 10.1177/1556264619831888.
Salloch S
BMC Med Ethics. 2018; 19(1):53.
PMID: 29871633
PMC: 5989368.
DOI: 10.1186/s12910-018-0295-0.
Malina R, Coelho-E-Silva M, Figueiredo A, Philippaerts R, Hirose N, Pena Reyes M
Sports Med. 2017; 48(4):991-1008.
PMID: 29082464
DOI: 10.1007/s40279-017-0799-7.
Wenner D
HEC Forum. 2015; 28(3):245-59.
PMID: 26613717
DOI: 10.1007/s10730-015-9298-0.
Does science need bioethicists? Ethics and science collaboration in biomedical research.
Kerasidou A, Parker M
Res Ethics. 2015; 10(4):214-226.
PMID: 26430467
PMC: 4587541.
DOI: 10.1177/1747016114554252.
Ethical considerations in malaria research proposal review: empirical evidence from 114 proposals submitted to an Ethics Committee in Thailand.
Adams P, Prakobtham S, Limphattharacharoen C, Vutikes P, Khusmith S, Pengsaa K
Malar J. 2015; 14:342.
PMID: 26370243
PMC: 4570222.
DOI: 10.1186/s12936-015-0854-5.
Latent variable modeling and its implications for institutional review board review: variables that delay the reviewing process.
Tzeng D, Wu Y, Hsu J
BMC Med Ethics. 2015; 16:57.
PMID: 26311634
PMC: 4551705.
DOI: 10.1186/s12910-015-0050-8.
Institutional Review Boards: Purpose and Challenges.
Grady C
Chest. 2015; 148(5):1148-1155.
PMID: 26042632
PMC: 4631034.
DOI: 10.1378/chest.15-0706.
Practice-Based Research Network Infrastructure Design for Institutional Review Board Risk Assessment and Generalizability of Clinical Results.
Curro F, Thompson V, Naftolin F, Grill A, Vena D, Terracio L
Ther Innov Regul Sci. 2015; 47(1):82-89.
PMID: 25949926
PMC: 4418503.
DOI: 10.1177/0092861512456284.
Institutional review boards: what's old? What's new? What needs to change?.
Kotsis S, Chung K
Plast Reconstr Surg. 2014; 133(2):439-445.
PMID: 24469174
PMC: 3905624.
DOI: 10.1097/01.prs.0000436846.00247.73.
Ethical reproducibility: towards transparent reporting in biomedical research.
Anderson J, Eijkholt M, Illes J
Nat Methods. 2013; 10(9):843-5.
PMID: 23985730
DOI: 10.1038/nmeth.2564.
Responsible conduct in nanomedicine research: environmental concerns beyond the common rule.
Resnik D
J Law Med Ethics. 2013; 40(4):848-55.
PMID: 23289687
PMC: 3616622.
DOI: 10.1111/j.1748-720X.2012.00713.x.
Reviews of functional MRI: the ethical dimensions of methodological critique.
Anderson J, Mizgalewicz A, Illes J
PLoS One. 2012; 7(8):e42836.
PMID: 22952615
PMC: 3429464.
DOI: 10.1371/journal.pone.0042836.
The ethics police?: IRBs' views concerning their power.
Klitzman R
PLoS One. 2011; 6(12):e28773.
PMID: 22174893
PMC: 3236766.
DOI: 10.1371/journal.pone.0028773.
Stem cell policy exceptionalism: proceed with caution.
Lomax G, Peckman S
Stem Cell Rev Rep. 2011; 8(2):299-304.
PMID: 21837381
DOI: 10.1007/s12015-011-9305-z.
Untapped ethical resources for neurodegeneration research.
Robillard J, Federico C, Tairyan K, Ivinson A, Illes J
BMC Med Ethics. 2011; 12:9.
PMID: 21635769
PMC: 3127846.
DOI: 10.1186/1472-6939-12-9.
Integrating utilization-focused evaluation with business process modeling for clinical research improvement.
Kagan J, Rosas S, Trochim W
Res Eval. 2011; 19(4):239-250.
PMID: 21552512
PMC: 3087184.
DOI: 10.3152/095820210X12827366906607.
A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn.
Abbott L, Grady C
J Empir Res Hum Res Ethics. 2011; 6(1):3-19.
PMID: 21460582
PMC: 3235475.
DOI: 10.1525/jer.2011.6.1.3.
Competing for patients: an ethical framework for recruiting patients with brain tumors into clinical trials.
Ibrahim G, Chung C, Bernstein M
J Neurooncol. 2011; 104(3):623-7.
PMID: 21318320
DOI: 10.1007/s11060-011-0536-2.
